Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 29
2007 41
2008 58
2009 54
2010 56
2011 69
2012 77
2013 80
2014 84
2015 73
2016 67
2017 52
2018 59
2019 66
2020 60
2021 71
2022 53
2023 51
2024 61
2025 69
2026 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,078 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Khan AA, et al. J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405. J Bone Miner Res. 2015. PMID: 25414052 Free article.
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on multidisciplinar …
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagn …
Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.
Ali DS, Khan AA, Morrison A, Tetradis S, Mirza RD, El Rabbany M, Abrahamsen B, Aghaloo TL, Al-Alwani H, Al-Dabagh R, Anastasilakis AD, Bhandari M, Body JJ, Brandi ML, Brignardello-Petersen R, Brown JP, Cheung AM, Compston J, Cooper C, Diez-Perez A, Ferrari SL, Guyatt G, Hanley D, Harvey NC, Josse RG, Kendler DL, Khan S, Kim S, Langdahl BL, Magopoulos C, Masri BK, Morgan SL, Morin SN, Napoli N, Obermayer-Pietsch B, Palermo A, Pepe J, Peters E, Pierroz DD, Rizzoli R, Saunders DP, Stanford CM, Sulimani R, Taguchi A, Tanaka S, Watts NB, Zamudio J, Zillikens MC, Ruggiero SL. Ali DS, et al. Endocr Pract. 2025 May;31(5):686-698. doi: 10.1016/j.eprac.2025.02.016. Endocr Pract. 2025. PMID: 40335186 Free article.
OBJECTIVE: Placement of a dental implant in a patient on antiresorptive therapy has been hypothesized to increase the risk of medication-related osteonecrosis of the jaw (MRONJ) and/or impact implant survival. In patients with osteoporosis, the risk of MRONJ …
OBJECTIVE: Placement of a dental implant in a patient on antiresorptive therapy has been hypothesized to increase the risk of medication-rel …
Medication-related osteonecrosis of the jaw: A literature review and update.
Kuroshima S, Al-Omari FA, Sasaki M, Sawase T. Kuroshima S, et al. Genesis. 2022 Sep;60(8-9):e23500. doi: 10.1002/dvg.23500. Epub 2022 Sep 15. Genesis. 2022. PMID: 36106755 Review.
Since the initial description of medication-related osteonecrosis of the jaw (MRONJ) almost two decades ago, the potential pathophysiology and risk factors have been elaborated on in many investigations and guidelines. ...Despite their different mechanisms of action …
Since the initial description of medication-related osteonecrosis of the jaw (MRONJ) almost two decades ago, the potential pat …
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons. Ruggiero SL, et al. J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5. J Oral Maxillofac Surg. 2014. PMID: 25234529
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial Surgeons (AAOMS) position papers in 2007 and 2009. ...
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaw (MRONJ) were set forth …
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ. Anastasilakis AD, et al. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888. J Clin Endocrinol Metab. 2022. PMID: 34922381 Free PMC article. Review.
CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) in patients with bone metastases (BM). Osteonecrosis of the jaw (ONJ) is a rare but severe condition manifested as necrotic bo …
CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) …
Bisphosphonate-associated osteonecrosis of the jaw.
Ferreira Jr LH Jr, Mendonça Jr KD Jr, Chaves de Souza J, Soares Dos Reis DC, do Carmo Faleiros Veloso Guedes C, de Souza Castro Filice L, Bruzadelli Macedo S, Soares Rocha F. Ferreira Jr LH Jr, et al. Minerva Dent Oral Sci. 2021 Feb;70(1):49-57. doi: 10.23736/S2724-6329.20.04306-X. Epub 2020 Sep 22. Minerva Dent Oral Sci. 2021. PMID: 32960522
INTRODUCTION: The purpose of this systematic review was to determine the possible risk factors related to pathophysiology of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and identify adequate treatment strategies available and success rates. EVIDEN …
INTRODUCTION: The purpose of this systematic review was to determine the possible risk factors related to pathophysiology of bisphosphona …
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis.
Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, Häuselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T. Everts-Graber J, et al. J Bone Miner Res. 2022 Feb;37(2):340-348. doi: 10.1002/jbmr.4472. Epub 2021 Nov 30. J Bone Miner Res. 2022. PMID: 34787342 Free article.
Osteonecrosis of the jaw (ONJ) is a rare but serious adverse event associated with antiresorptive treatment. ...Subjects who underwent at least one dual-energy X-ray absorptiometry (DXA) examination were included in the osteoporosis register of the Swiss Soci …
Osteonecrosis of the jaw (ONJ) is a rare but serious adverse event associated with antiresorptive treatment. ...Subjects who u …
Bisphosphonate-Related Osteonecrosis of the Jaw.
Chien HI, Chen LW, Liu WC, Lin CT, Ho YY, Tsai WH, Yang KC. Chien HI, et al. Ann Plast Surg. 2021 Feb 1;86(2S Suppl 1):S78-S83. doi: 10.1097/SAP.0000000000002650. Ann Plast Surg. 2021. PMID: 33346545
OBJECTIVES: Antiresorptive agents for bone pain were widely used to treat patients with advanced osteoporosis, multiple myeloma, and bone metastatic cancer. In recent years, however, bisphosphonate-related osteonecrosis of the jaw (BRONJ) has been a ra …
OBJECTIVES: Antiresorptive agents for bone pain were widely used to treat patients with advanced osteoporosis, multiple myeloma, and …
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M, Kuroshima S, Sawase T. Kawahara M, et al. Int J Implant Dent. 2021 May 14;7(1):47. doi: 10.1186/s40729-021-00323-0. Int J Implant Dent. 2021. PMID: 33987769 Free PMC article. Review.
BACKGROUND: Medication-related osteonecrosis of the jaw (MRONJ), which was first reported as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in bisphosphonate users, is a rare but severe soft and hard tissue disease induced by sev …
BACKGROUND: Medication-related osteonecrosis of the jaw (MRONJ), which was first reported as bisphosphonate-related …
Dental Implant Failure and Medication-Related Osteonecrosis of the Jaw Related to Dental Implants in Patients Taking Antiresorptive Therapy for Osteoporosis: A Systematic Review and Meta-Analysis.
Mirza R, El Rabbany M, Ali DS, Tetradis S, Morrison A, Ruggiero S, Alnajimi R, Khan AA, Guyatt G. Mirza R, et al. Endocr Pract. 2025 Sep;31(9):1189-1196. doi: 10.1016/j.eprac.2025.06.003. Epub 2025 Jun 10. Endocr Pract. 2025. PMID: 40505730 Free article.
OBJECTIVES: To inform the 2024 International Task Force on Osteonecrosis of the Jaw update, we conducted a systematic review and meta-analysis evaluating dental implant failure and medication-related osteonecrosis of the jaw (MRONJ) related to antireso …
OBJECTIVES: To inform the 2024 International Task Force on Osteonecrosis of the Jaw update, we conducted a systematic review a …
1,078 results